647 filings
Page 3 of 33
8-K
tvziyth4t6c4j8e39hg
17 Aug 20
Other Events
4:41pm
NT 10-Q
pqs3vuxtji zn
10 Aug 20
Notice of late quarterly filing
9:35pm
8-K
t11da58if zop1
6 Aug 20
Amag Pharmaceuticals Announces Second Quarter 2020 Financial Results
7:06am
8-K
jww6zjq h9ei
27 Jul 20
Amag Pharmaceuticals Completes Divestment of Women’s Health Assets
7:38am
8-K
ce89u52kk337b01
23 Jul 20
Amag Pharmaceuticals and Norgine B.V. Enter into Exclusive Licensing Agreement to Commercialize Ciraparantag In Europe, Australia and New Zealand
9:24am
8-K
0nfo5w
11 Jun 20
Amag Pharmaceuticals Announces Leadership Changes
7:13am
8-K
cfesolwluenz
4 Jun 20
Submission of Matters to a Vote of Security Holders
4:41pm
8-K
nlu5www91zlr 6i2b
21 May 20
Amag Pharmaceuticals Completes Sale of Its Rights to Intrarosa® to Millicent Pharma for Up to $125 Million
9:34pm
8-K
6jluyslt
11 May 20
Amag Pharmaceuticals Announces First Quarter 2020 Financial Results
7:18am
CT ORDER
6o58782
6 May 20
Confidential treatment order
2:51pm
CT ORDER
j3w2xt
6 May 20
Confidential treatment order
2:51pm
CT ORDER
cktthp3mca2rgo8c3
6 May 20
Confidential treatment order
2:50pm
CT ORDER
kgh8dx2oj
6 May 20
Confidential treatment order
2:49pm
8-K
dluuv1v6cvkls7levxnx
28 Apr 20
AMAG Pharmaceuticals Appoints Scott Myers as President and Chief Executive Officer
7:34am
8-K
nbyi829yhvt rju2hl7
16 Apr 20
Amag Pharmaceuticals Provides COVID-19 Company Update
7:45am